Leukemia Thrapeutics Market – Industry Trends and Forecast to 2027
The growth of Leukemia Therapeutics Market p ropelled by the rise in cases of leukemia therapeutics which further develop a room for introduction of novel therapy and rich promising pipeline drugs. Although , multiple treatment landscape and family history of leukemia therapeutics are believed as positive indicator for the demand of novel drugs. The market for leukemia therapeutics market is majorly hamper by multiple patent termination along with high treatment cost. The L eukemia T herapeutics M arket is projected to attain US D 17 billion by 2024 from USD 12 billion in 2019, at a CAGR of 6.5% through the forecast period Market growth is essentially driven by the rising prevalence of chronic myeloid leukemia (CML), chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and acute lymphocytic leukemia (ALL), and increasing approvals of innovative and novel drugs and immunotherapies. Leukemia also referred to as blood cancer hinders ability of a per...